Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs.
Saved in:
| Title: | Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs. |
|---|---|
| Authors: | Fletcher RE; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nunes NS; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Patterson MT; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Vinod N; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Khan SM; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mendu SK; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Li X; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., de Paula Pohl A; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Wachsmuth LP; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Choo-Wosoba H; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Eckhaus MA; Division of Veterinary Resources, Office of Research Services, Office of the Director, National Institutes of Health, Bethesda, MD., Venzon DJ; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Kanakry CG; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. |
| Source: | Blood advances [Blood Adv] 2023 Apr 11; Vol. 7 (7), pp. 1117-1129. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36595377 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fletcher+RE%22">Fletcher RE</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Nunes+NS%22">Nunes NS</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Patterson+MT%22">Patterson MT</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Vinod+N%22">Vinod N</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Khan+SM%22">Khan SM</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Mendu+SK%22">Mendu SK</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22de+Paula+Pohl+A%22">de Paula Pohl A</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Wachsmuth+LP%22">Wachsmuth LP</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Choo-Wosoba+H%22">Choo-Wosoba H</searchLink>; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Eckhaus+MA%22">Eckhaus MA</searchLink>; Division of Veterinary Resources, Office of Research Services, Office of the Director, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Venzon+DJ%22">Venzon DJ</searchLink>; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Kanakry+CG%22">Kanakry CG</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2023 Apr 11; Vol. 7 (7), pp. 1117-1129. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36595377 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2022007026 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1117 Titles: – TitleFull: Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fletcher RE – PersonEntity: Name: NameFull: Nunes NS – PersonEntity: Name: NameFull: Patterson MT – PersonEntity: Name: NameFull: Vinod N – PersonEntity: Name: NameFull: Khan SM – PersonEntity: Name: NameFull: Mendu SK – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: de Paula Pohl A – PersonEntity: Name: NameFull: Wachsmuth LP – PersonEntity: Name: NameFull: Choo-Wosoba H – PersonEntity: Name: NameFull: Eckhaus MA – PersonEntity: Name: NameFull: Venzon DJ – PersonEntity: Name: NameFull: Kanakry CG IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 04 Text: 2023 Apr 11 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 7 – Type: issue Value: 7 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |